|4May 6, 3:53 PM ET

NEOGENOMICS INC 4

4 · NEOGENOMICS INC · Filed May 6, 2015

Insider Transaction Report

Form 4
Period: 2015-05-04
BRODIE STEVEN G.
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2015-05-04$4.78/sh+120,000$573,600120,000 total
    Exercise: $4.78From: 2016-05-04Exp: 2020-05-04Common Stock (0 underlying)
Holdings
  • Common Stock

    4,482
  • Stock Option (Right to Buy)

    Exercise: $1.48From: 2012-05-16Exp: 2016-05-16Common Stock (0 underlying)
    50,000
  • Stock Option (Right to Buy)

    Exercise: $3.76From: 2014-04-16Exp: 2018-04-16Common Stock (0 underlying)
    10,000
  • Stock Option (Right to Buy)

    Exercise: $1.69From: 2012-04-12Exp: 2017-04-12Common Stock (0 underlying)
    10,000
  • Stock Option (Right to Buy)

    Exercise: $3.45From: 2015-03-05Exp: 2019-03-05Common Stock (0 underlying)
    20,000
Footnotes (5)
  • [F1]On May 16, 2011 Dr. Brodie was granted 50,000 stock options. The options vest ratably over the first four anniversary dates of the grant date.
  • [F2]On April 12, 2012 Dr. Brodie was granted 10,000 stock options. There was immediate vesting of 2,500 shares and then 2,500 shares will vest on the next three anniversary dates of the grant date.
  • [F3]On April 16, 2013 Dr. Brodie was granted 10,000 stock options. These options will vest ratably over the next three anniversary dates of the grant date.
  • [F4]On March 5, 2014 Dr. Brodie was granted 20,000 stock options. The options will vest ratably over the next three anniversary dates of the grant date.
  • [F5]On May 4, 2015 Dr. Brodie was granted 120,000 stock options. The options vest ratably over the next three anniversary dates of the grant date.

Documents

1 file
  • 4
    form474341_20150506035309-.xmlPrimary